Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci
Vancomycin-resistant enterococci (VRE) account for a large proportion of hospital-acquired infections. Determining optimal treatment of VRE urinary tract infections (UTIs) is challenging. The purpose of this study was to determine if a difference in efficacy or safety exists between linezolid and no...
Saved in:
Main Authors: | Mary Joyce Wingler (Author), Neel R. Patel (Author), S. Travis King (Author), Jamie L. Wagner (Author), Katie E. Barber (Author), Kayla R. Stover (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravenous versus Oral Step-Down for the Treatment of <i>Staphylococcus aureus</i> Bacteremia in a Pediatric Population
by: Sarah Grace Gunter, et al.
Published: (2022) -
Synergism of Linezolid and Rifampin to Combat Multidrug-Resistant Environmental Enterococci Isolates
by: Mobina Noori, et al.
Published: (2022) -
Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant Enterococci
by: Eric Mühlberg, et al.
Published: (2020) -
Virulence and Antimicrobial Resistance in Enterococci Isolated from Urinary Tract Infections
by: Ahad Bazmani, et al.
Published: (2013) -
Genomic epidemiology reveals multiple mechanisms of linezolid resistance in clinical enterococci in China
by: Ziran Wang, et al.
Published: (2024)